Nader Pourhassan and Kazem Kazempour

SEC Charges Former Biotech CEO with Fraud, Insider Trading; Research Firm CEO Also Charged in Scheme

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like
Read More

John David Gessin et al.

On March 14, the Securities and Exchange Commission charged John David Gessin and two of his businesses, Equifunds,…
Read More

Cronin and Joseph

Litigation Release No. 25493 / September 1, 2022 Securities and Exchange Commission v. Cronin and Joseph, No. 22-mc-248…